TGM2 and hepatocellular carcinoma: In addition to the retinoic acid-binding proteins and nuclear receptors [11–13], our study reported for the first time that TG2 is a novel binding protein of ACR and highlighted a potential mechanism of the anti-HCC effect of ACR independent retinoic acid receptor pathways.